While the past decade has seen the development of multiple new interventions to diagnose and treat cancer, as well as to improve the quality of life for cancer patients, many of these interventions have substantial costs. This has resulted in increased scrutiny of the costs of care for cancer, as well as the costs relative to the benefits for cancer treatments. It is important for oncologists and other members of the cancer community to consider and understand how economic evaluations of cancer interventions are performed and to be able to use and critique these evaluations. This review discusses the components, main types, and analytic issues of health economic evaluations using studies of cancer interventions as examples. We also highlight limitations of these economic evaluations and discuss why members of the cancer community should care about economic analyses.

中文翻译：

---

癌症患者医疗干预的经济评估：如何、为什么和意味着什么？

尽管在过去十年中出现了多种新的干预措施来诊断和治疗癌症以及改善癌症患者的生活质量，但其中许多干预措施的成本很高。这导致了对癌症护理成本以及与癌症治疗收益相关的成本的更多审查。对于肿瘤学家和癌症界的其他成员来说，考虑和了解如何对癌症干预进行经济评估并能够使用和批评这些评估非常重要。本综述以癌症干预研究为例，讨论了健康经济评估的组成部分、主要类型和分析问题。